Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

By B. Langford, M. So, S. Raybardhan, V. Leung, Duncan J Westwood, D. Macfadden, Jean-Paul R. Soucy, N. Daneman. Clinical Microbiology and Infection, 2020

1,360 citations recorded by the source corpus.

Background Bacterial co-pathogens are commonly identified in viral respiratory infections and are important causes of morbidity and mortality. The prevalence of bacterial infection in patients infected with SARS-CoV-2 is not well understood. Aims To determine the prevalence of bacterial co-infection (at presentation) and secondary infection (after presentation) in patients with COVID-19. Sources We performed a systematic search of MEDLINE, OVID Epub and EMBASE databases for English language literature from 2019 to April 16, 2020. Studies were included if they (a) evaluated patients with confirmed COVID-19 and (b) reported the prevalence of acute bacterial infection. Content Data were extracted by a single reviewer and cross-checked by a second reviewer. The main outcome was the proportion of COVID-19 patients with an acute bacterial infection. Any bacteria detected from non-respiratory-tract or non-bloodstream sources were excluded. Of 1308 studies screened, 24 were eligible and included in the rapid review representing 3338 patients with COVID-19 evaluated for acute bacterial infection. In the meta-analysis, bacterial co-infection (estimated on presentation) was identified in 3.5% of patients (95%CI 0.4–6.7%) and secondary bacterial infection in 14.3% of patients (95%CI 9.6–18.9%). The overall proportion of COVID-19 patients with bacterial infection was 6.9% (95%CI 4.3–9.5%). Bacterial infection was more common in critically ill patients (8.1%, 95%CI 2.3–13.8%). The majority of patients with COVID-19 received antibiotics (71.9%, 95%CI 56.1 to 87.7%). Implications Bacterial co-infection is relatively infrequent in hospitalized patients with COVID-19. The majority of these patients may not require empirical antibacterial treatment.

Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/b56882f4589bfd92000d777cb97fe6234eba45d6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Yun Kit Yeoh
  2. G. Lui
  3. Fen Zhang
  4. T. Zuo
  5. P. Chan
  6. Qin Liu
  7. A. Li
  8. E. Tso

Citations in the corpus